MXPA02011481A - Derivados de disulfuro que son utiles para el tratamiento de enfermedades alergicas. - Google Patents

Derivados de disulfuro que son utiles para el tratamiento de enfermedades alergicas.

Info

Publication number
MXPA02011481A
MXPA02011481A MXPA02011481A MXPA02011481A MXPA02011481A MX PA02011481 A MXPA02011481 A MX PA02011481A MX PA02011481 A MXPA02011481 A MX PA02011481A MX PA02011481 A MXPA02011481 A MX PA02011481A MX PA02011481 A MXPA02011481 A MX PA02011481A
Authority
MX
Mexico
Prior art keywords
disulfide derivatives
allergic diseases
treating allergic
derivatives useful
treating
Prior art date
Application number
MXPA02011481A
Other languages
English (en)
Spanish (es)
Inventor
Mark R Hellberg
Original Assignee
Alcon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Inc filed Critical Alcon Inc
Publication of MXPA02011481A publication Critical patent/MXPA02011481A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/39Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
    • C07C323/43Y being a hetero atom
    • C07C323/44X or Y being nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/04Antipruritics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/14Decongestants or antiallergics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
MXPA02011481A 2000-05-19 2001-04-25 Derivados de disulfuro que son utiles para el tratamiento de enfermedades alergicas. MXPA02011481A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20582700P 2000-05-19 2000-05-19
PCT/US2001/013331 WO2001090060A1 (en) 2000-05-19 2001-04-25 Disulfide derivatives useful for treating allergic diseases

Publications (1)

Publication Number Publication Date
MXPA02011481A true MXPA02011481A (es) 2003-06-06

Family

ID=22763799

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA02011481A MXPA02011481A (es) 2000-05-19 2001-04-25 Derivados de disulfuro que son utiles para el tratamiento de enfermedades alergicas.

Country Status (19)

Country Link
US (3) US6492552B2 (enExample)
EP (1) EP1282599B1 (enExample)
JP (1) JP2003534318A (enExample)
KR (1) KR20030007589A (enExample)
CN (2) CN1175807C (enExample)
AR (1) AR028566A1 (enExample)
AT (1) ATE330938T1 (enExample)
AU (2) AU2001255675B2 (enExample)
BR (1) BR0110943A (enExample)
CA (1) CA2407964A1 (enExample)
CY (1) CY1105164T1 (enExample)
DE (1) DE60120961T2 (enExample)
DK (1) DK1282599T3 (enExample)
ES (1) ES2261402T3 (enExample)
MX (1) MXPA02011481A (enExample)
PL (1) PL365457A1 (enExample)
PT (1) PT1282599E (enExample)
WO (1) WO2001090060A1 (enExample)
ZA (1) ZA200208840B (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1173697C (zh) * 2000-05-19 2004-11-03 爱尔康公司 用于治疗过敏性疾病的苯胺二硫化物衍生物
US7645903B2 (en) 2002-10-31 2010-01-12 Ge Healthcare Bio-Sciences Ab Use of urea variants as affinity ligands
AU2005259911A1 (en) * 2004-06-28 2006-01-12 Alcon, Inc. Topical formulations for treating allergic diseases
WO2006069282A2 (en) * 2004-12-22 2006-06-29 California Institute Of Technology Degradable p0lymers and methods of preparation thereof
US20130011378A1 (en) 2011-06-17 2013-01-10 Tzung-Horng Yang Stable formulations of a hyaluronan-degrading enzyme
KR20140043438A (ko) * 2011-06-17 2014-04-09 할로자임, 아이엔씨 히알루로난 분해 효소의 안정한 제형
FR3057264B1 (fr) * 2016-10-12 2020-05-29 Arkema France Composes porteurs de groupes associatifs azotes
CN108586299B (zh) * 2018-06-06 2020-06-16 北京化工大学 一种可引发、聚合及降低体积收缩的芳香二硫化合物的制备方法及用途

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1232787A (enExample) 1967-08-08 1971-05-19
US3663616A (en) 1969-10-13 1972-05-16 Sherwin Williams Co Bis(2-carbamylphenyl)disulfides
EP0006227B1 (en) 1978-06-16 1984-12-27 Kyowa Hakko Kogyo Co., Ltd Antithrombotic pharmaceutical preparation containing 2,2'-dithiobis benzamide derivatives and new 2,2'-dithiobis benzamide derivatives
US4923892A (en) 1985-08-17 1990-05-08 Burroughs Wellcome Co. Tricyclic aromatic compounds
GB8520662D0 (en) 1985-08-17 1985-09-25 Wellcome Found Tricyclic aromatic compounds
JPS6310784A (ja) 1986-03-03 1988-01-18 Kyowa Hakko Kogyo Co Ltd 抗アレルギー剤
GB9020933D0 (en) 1990-09-26 1990-11-07 Ici Plc Compound,preparation and use
US5859017A (en) 1994-04-01 1999-01-12 Cell Therapeutics, Inc. Method for inhibiting mast cell and basophil activation
US5463122A (en) 1994-08-05 1995-10-31 Warner-Lambert Company Arylthio compounds
US5734081A (en) 1994-08-05 1998-03-31 Warner-Lambert Company Arylthio compounds
US6001555A (en) 1994-09-23 1999-12-14 The United States Of America As Represented By The Department Of Health And Human Services Method for identifying and using compounds that inactivate HIV-1 and other retroviruses by attacking highly conserved zinc fingers in the viral nucleocapsid protein
JPH095926A (ja) * 1995-04-18 1997-01-10 Fuji Photo Film Co Ltd 熱現像感光材料
US5641805A (en) 1995-06-06 1997-06-24 Alcon Laboratories, Inc. Topical ophthalmic formulations for treating allergic eye diseases
US6225327B1 (en) 1996-04-18 2001-05-01 Alcon Laboratories, Inc. Compounds which inhibit human conjunctival mast cell degranulation for treating ocular allergic-type complications
JP2894445B2 (ja) 1997-02-12 1999-05-24 日本たばこ産業株式会社 Cetp活性阻害剤として有効な化合物
JP3940201B2 (ja) 1997-05-20 2007-07-04 大塚製薬株式会社 3,3’−ジチオジベンゾヒドロキサム酸

Also Published As

Publication number Publication date
AR028566A1 (es) 2003-05-14
HK1050185A1 (en) 2003-06-13
CN1241912C (zh) 2006-02-15
JP2003534318A (ja) 2003-11-18
DE60120961D1 (de) 2006-08-03
US6506802B2 (en) 2003-01-14
KR20030007589A (ko) 2003-01-23
AU5567501A (en) 2001-12-03
EP1282599A1 (en) 2003-02-12
WO2001090060A1 (en) 2001-11-29
US20020193634A1 (en) 2002-12-19
US20020058709A1 (en) 2002-05-16
DE60120961T2 (de) 2006-11-16
PT1282599E (pt) 2006-08-31
EP1282599B1 (en) 2006-06-21
PL365457A1 (en) 2005-01-10
US6500864B1 (en) 2002-12-31
DK1282599T3 (da) 2006-07-31
ATE330938T1 (de) 2006-07-15
CY1105164T1 (el) 2010-03-03
CN1429209A (zh) 2003-07-09
AU2001255675B2 (en) 2005-04-14
CN1616422A (zh) 2005-05-18
US20020193633A1 (en) 2002-12-19
US6492552B2 (en) 2002-12-10
BR0110943A (pt) 2004-01-06
CA2407964A1 (en) 2001-11-29
ZA200208840B (en) 2003-12-02
CN1175807C (zh) 2004-11-17
ES2261402T3 (es) 2006-11-16

Similar Documents

Publication Publication Date Title
MXPA03011947A (es) Formulaciones de olopatidina para administracion topica.
BRPI0418245A (pt) nitróxi-derivados de prostaglandina
IS2648B (is) Amínósýklóhexýletersambönd og notkun þeirra
ES2196396T3 (es) Compuestos heteroaromaticos de 5 miembros conteniendo oxigeno o azufre como inhibidores del factor xa.
NO20071843L (no) Substituerte anilinderivater
MXPA02011481A (es) Derivados de disulfuro que son utiles para el tratamiento de enfermedades alergicas.
MXPA05010000A (es) Derivados de p-diaminobenceno substituidos.
BR0307071A (pt) ésteres hidroxamato do ácido n-(fenil 4-substituìdo)-antranìlico
PE20030061A1 (es) 1-biaril-1,8-naftiridin-4-ona como inhibidores de fosfodiesterasa-4
BRPI0509220A (pt) método, formulação oftálmica e kit para para o tratamento de olho ressecado moderno a grave; método para o tratamento de olho ressecado crÈnico; e métodos para reduzir a vermelhidão e a produção de citocinas inflamatórias por células no epitélio
SE9802794D0 (sv) New compounds
NO20051893L (no) Ny forbindelse
ECSP055844A (es) Nuevos compuestos triciclicos
TR200000907T2 (tr) Nötrofil elastaz inhibitörleri olarak pirolopirolon türevleri.
ITMI922263A1 (it) Ammine eterocicliche utili nella terapia dell'asma e dell'infiammazione delle vie aeree
AR030817A1 (es) Derivados de diazacicloalcanodiona
MY139368A (en) Novel cyclohexyl sulphones
TR200103457T2 (tr) 4-Fenil-Pirimidin Türevleri.
NZ500300A (en) Compositions containing N-(3,4-dimethoxycinnamoyl) anthranilic acid for the treatment of excessive proliferation of retinal pigment epithelial cells
NO20065662L (no) Esterlinkede makrolider nyttige for behandlingen av mikrobielle infeksjoner
PL365459A1 (en) Aniline disulfide derivatives for treating allergic diseases
TR200103004T2 (tr) Pirolidinkarbonilamino siklik disülfitler.
WO2004039822A3 (en) 4’’ - modified erythromycin derivatives
MXPA02011482A (es) Composiciones que contienen un derivado de disulfuro de benzamida para tratar enfermedades.
TW200503709A (en) Itching treating agent containing piperidine derivative as active ingredient

Legal Events

Date Code Title Description
FG Grant or registration